Newly-released Biopsy Guidance System Market analysis report by Future Market Insights shows that global sales of the Biopsy Guidance System Market in 2021 were held at USD 1.1 Billion. With a CAGR of 5.8% from 2022 to 2032, the market is projected to reach a valuation of USD 2 Billion by 2032. The market for Stereotactic Guided Biopsy is expected to be the highest revenue-generating segment expected to grow at a CAGR of 6.1% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global Biopsy Guidance System Market (2022) | USD 458 Million |
| Global Biopsy Guidance System Market (2032) | USD 2 Billion |
| Global Biopsy Guidance System Market CAGR (2022 to 2032) | 5.8% |
| USA Biopsy Guidance System Market (2022) | USD 444 Million |
| Key Companies Profiled | Becton, Dickinson, and Company; Hologic, Inc.; Devicor Medical Products, Inc.; B. Braun Melsungen AG; ARGON MEDICAL; Boston Scientific Corporation; INRAD Inc.; Cook Medical; PLANMED OY |
As per the Biopsy Guidance System Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Biopsy Guidance System Market increased at around 5.1% CAGR.
The rising prevalence of cancer, the rise in the geriatric population, the rising demand for non-invasive procedures, technological innovations, and government initiatives, are the key drivers for the market. A biopsy is one of the most common procedures for diagnosing cancer and other chronic diseases, and it is used to diagnose breast, brain, skin, and prostate cancers.
The rising incidence of cancer is one of the major drivers of market expansion. Because the biopsy guidance system is one of the most important requirements for the initial diagnosis of cancer, the market is expected to grow at a rapid pace over the forecast period.
As a result of the substantial increase in the incidence of cancer, more advanced technology, safer, and more effective biopsies are being developed, which is driving the biopsy market. Non-invasive procedures are becoming more popular, which is fueling market growth in that area.
Patients owing to the high costs and painful side effects that come with this treatment, resulting in undiagnosed or inadequate diseases later in life, often avoid invasive biopsies. These symptoms consequently increase mortality rates and lead to greater expenses and difficulties in treatment.
The demand for non-invasive procedures is skyrocketing owing to the boost in demand for biopsy guidance systems, resulting in a surge in the need for biopsy guidance systems. Patients recover faster and are less traumatized as a result of these procedures. Owing to these factors, Biopsy Guidance System Market is projected to grow at a CAGR of 5.8 % over the coming 10 years.
When the tumor is located deep within the body, image-guided biopsies are used. Biopsy guidance systems are both cost-effective and simple to operate. They can provide superb real-time details that cause the procedure to be less uncomfortable and more efficient for the patient. Furthermore, these guided biopsies can enable to rapid inspect numerous lesions in the axillary and sub-areolar areas.
The segment is growing due to the rising demand for robotic biopsies due to their less invasive nature. A rising number of product launches, combined with quick FDA approval, are also contributing to the segment's growth.
Increased awareness of biopsy guidance systems, increased healthcare infrastructure development, impressive reimbursement policies, increased investment in healthcare research and development, and an upsurge in the number of hospitals and diagnostic centers are expected to drive demand for biopsy guidance systems during the forecast period.
North America accounts for the largest market share during the forecast period. Because of factors such as improved infrastructure, rising patient awareness, and the presence of key players in the region also the presence of a large number of academic institutes, enhanced healthcare infrastructure, and Research and Development institutes are all contributing to the market's growth. In addition, the USA has a large number of market participants.
On the other hand, the market in the Asia Pacific is expected to grow at the fastest pace with an absolute dollar opportunity of USD 880 Million during the forecast period. The presence of leading manufacturers in countries such as Japan, as well as a growing number of local producers in countries like China and India, are driving the regional market forward.
Over the projected period, the market is expected to be fuelled by an increasing number of healthcare institutions, the rising need for diagnostic centers, and expanding Research and Development projects. The market is expected to grow over the forecast period, owing to an increase in the number of cancer cases and advancements in biopsy guidance systems.
The USA is expected to account for the largest market of USD 771.4 Million by the end of 2032. This is attributable to a significant increase in research & development activities. Furthermore, advances in the healthcare industry have resulted in the development of new technologies and equipment, which is further expected to boost the market in the USA. Furthermore, the presence of well-known corporations, as well as early access to new and developing technologies, is projected to aid the market in the USA in maintaining its global market supremacy in the next years.
The market in China is expected to grow at a CAGR of 7.1% during the forecast period, approaching a market revenue of USD 230.9 Million by 2032. In Asian countries, traditional biopsy techniques such as core-needle biopsies and surgical biopsies continue to dominate the cancer diagnostic market. A significant increase in cancer incidence is a major driver of regional market expansion.
The market in the UK is projected to reach a valuation of USD 89 Million by 2032, growing at a CAGR of 6.5% from 2022 to 2032. During this period, the market is projected to garner an absolute dollar opportunity of USD 41 Million.
In Japan, the market is expected to reach USD 78 Million by 2032. Growing at a CAGR of 7.1% from 2022 to 2032, the market in the country is expected to gross an absolute dollar opportunity of around USD 39 Million.
During the forecast period, the stereotactically guided biopsy segment is anticipated to experience rapid expansion. New product launches, originating with new and improved product efficacy, and the introduction of technological advances using 2D-3D image guidance, will help propel the segment forward.
The combination of increased awareness and the introduction of innovative medical technologies has led to an increased demand for stereotactic-guided biopsies. In addition, the introduction of automated core biopsy guns has boosted the popularity of this method. Several medical facilities have broadened the use of stereotactic-guided biopsy to all challenging mammographic lesions.
Over the forecast period, the ultrasound-guided biopsy segment is expected to increase at the fastest rate. It is the safest and most effective imaging technique for targeting fine-needle aspirations and percutaneous biopsies. Using real-time imaging, it is a secure and controllable method for targeting needles for abdominal and pelvic tissues and masses.
It has several advantages in comparison to CT-guided biopsies, such as portability, cost, and the lack of ionizing radiation. In a safe fashion, the procedure can be carried out on a variety of lesions that are as small as 1 cm. Therefore, an ultrasound-guided biopsy is becoming increasingly popular among patients.
With many local firms vying against multinational competitors, the market is significantly fragmented. To stay competitive in the industry, major businesses are focusing more on research and development of new products.
The prominent players in the Biopsy Guidance System Market are Becton, Dickinson, and Company, Hologic, Inc., Devicor Medical Products, Inc., B. Braun Melsungen AG, and ARGON MEDICAL. Major market players use a variety of methods to preserve their dominance, including high Research and Development activity, global expansion strategies, broad product offers, and frequent introduction of advanced versions of existing items.
Some of the recent developments of key Biopsy Guidance System providers are as follows:
Similarly, the team at Future Market Insights, which is available in the full report, has tracked recent developments related to companies offering Biopsy Guidance Systems.
Table 1: Global Market Value (US$ Million), By Product Type, 2017 to 2021
Table 2: Global Market Value (US$ Million), By Product Type, 2022 to 2032
Table 3: Global Market Value (US$ Million), By End-User, 2017 to 2021
Table 4: Global Market Value (US$ Million), By End-User, 2022 to 2032
Table 5: Global Market Value (US$ Million), By Application, 2017 to 2021
Table 6: Global Market Value (US$ Million), By Application, 2022 to 2032
Table 7: Global Market, By Region, 2017 to 2021
Table 8: Global Market, By Region, 2022 to 2032
Table 9: North America Market Value (US$ Million), By Product Type, 2017 to 2021
Table 10: North America Market Value (US$ Million), By Product Type, 2022 to 2032
Table 11: North America Market Value (US$ Million), By End-User, 2017 to 2021
Table 12: North America Market Value (US$ Million), By End-User, 2022 to 2032
Table 13: North America Market Value (US$ Million), By Application, 2017 to 2021
Table 14: North America Market Value (US$ Million), By Application, 2022 to 2032
Table 15: North America Market, By Country, 2017 to 2021
Table 16: North America Market, By Country, 2022 to 2032
Table 17: Latin America Market Value (US$ Million), By Product Type, 2017 to 2021
Table 18: Latin America Market Value (US$ Million), By Product Type, 2022 to 2032
Table 19: Latin America Market Value (US$ Million), By End-User, 2017 to 2021
Table 20: Latin America Market Value (US$ Million), By End-User, 2022 to 2032
Table 21: Latin America Market Value (US$ Million), By Application, 2017 to 2021
Table 22: Latin America Market Value (US$ Million), By Application, 2022 to 2032
Table 23: Latin America Market, By Country, 2017 to 2021
Table 24: Latin America Market, By Country, 2022 to 2032
Table 25: Europe Market Value (US$ Million), By Product Type, 2017 to 2021
Table 26: Europe Market Value (US$ Million), By Product Type, 2022 to 2032
Table 27: Europe Market Value (US$ Million), By End-User, 2017 to 2021
Table 28: Europe Market Value (US$ Million), By End-User, 2022 to 2032
Table 29: Europe Market Value (US$ Million), By Application, 2017 to 2021
Table 30: Europe Market Value (US$ Million), By Application, 2022 to 2032
Table 31: Europe Market, By Country, 2017 to 2021
Table 32: Europe Market, By Country, 2022 to 2032
Table 33: Asia Pacific Market Value (US$ Million), By Product Type, 2017 to 2021
Table 34: Asia Pacific Market Value (US$ Million), By Product Type, 2022 to 2032
Table 35: Asia Pacific Market Value (US$ Million), By End-User, 2017 to 2021
Table 36: Asia Pacific Market Value (US$ Million), By End-User, 2022 to 2032
Table 37: Asia Pacific Market Value (US$ Million), By Application, 2017 to 2021
Table 38: Asia Pacific Market Value (US$ Million), By Application, 2022 to 2032
Table 39: Asia Pacific Market, By Country, 2017 to 2021
Table 40: Asia Pacific Market, By Country, 2022 to 2032
Table 41: MEA Market Value (US$ Million), By Product Type, 2017 to 2021
Table 42: MEA Market Value (US$ Million), By Product Type, 2022 to 2032
Table 43: MEA Market Value (US$ Million), By End-User, 2017 to 2021
Table 44: MEA Market Value (US$ Million), By End-User, 2022 to 2032
Table 45: MEA Market Value (US$ Million), By Application, 2017 to 2021
Table 46: MEA Market Value (US$ Million), By Application, 2022 to 2032
Table 47: MEA Market, By Country, 2017 to 2021
Table 48: MEA Market, By Country, 2022 to 2032
Table 49: Global Market Incremental $ Opportunity, By Product Type, 2017 to 2021
Table 50: Global Market Incremental $ Opportunity, By End-User, 2022 to 2032
Table 51: Global Market Incremental $ Opportunity, By Application, 2017 to 2021
Table 52: Global Market Incremental $ Opportunity, By Region, 2022 to 2032
Table 53: North America Market Incremental $ Opportunity, By Product Type, 2017 to 2021
Table 54: North America Market Incremental $ Opportunity, By End-User, 2022 to 2032
Table 55: North America Market Incremental $ Opportunity, By Application, 2017 to 2021
Table 56: North America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 57: Latin America Market Incremental $ Opportunity, By Product Type, 2017 to 2021
Table 58: Latin America Market Incremental $ Opportunity, By End-User, 2022 to 2032
Table 59: Latin America Market Incremental $ Opportunity, By Application, 2017 to 2021
Table 60: Latin America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 61: Europe Market Incremental $ Opportunity, By Product Type, 2017 to 2021
Table 62: Europe Market Incremental $ Opportunity, By End-User, 2022 to 2032
Table 63: Europe Market Incremental $ Opportunity, By Application, 2017 to 2021
Table 64: Europe Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 65: Asia Pacific Market Incremental $ Opportunity, By Product Type, 2017 to 2021
Table 66: Asia Pacific Market Incremental $ Opportunity, By End-User, 2022 to 2032
Table 67: Asia Pacific Market Incremental $ Opportunity, By Application, 2017 to 2021
Table 68: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 69: MEA Market Incremental $ Opportunity, By Product Type, 2017 to 2021
Table 70: MEA Market Incremental $ Opportunity, By End-User, 2022 to 2032
Table 71: MEA Market Incremental $ Opportunity, By Application, 2017 to 2021
Table 72: MEA Market Incremental $ Opportunity, By Country, 2022 to 2032
Figure 1: Global Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032
Figure 2: Global Market Absolute $ Historical Gain (2017 to 2021) and Opportunity (2022 to 2032), US$ Million
Figure 3: Global Market Share, By Product Type, 2022 to 2032
Figure 4: Global Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032
Figure 5: Global Market Attractiveness Index, By Product Type - 2022 to 2032
Figure 6: Global Market Share, By End-User, 2022 to 2032
Figure 7: Global Market Y-o-Y Growth Projections, By End-User - 2022 to 2032
Figure 8: Global Market Attractiveness Index, By End-User - 2022 to 2032
Figure 9: Global Market Share, By Application, 2022 to 2032
Figure 10: Global Market Y-o-Y Growth Projections, By Application - 2022 to 2032
Figure 11: Global Market Attractiveness Index, By Application - 2022 to 2032
Figure 12: Global Market Share, By Region, 2022 to 2032
Figure 13: Global Market Y-o-Y Growth Projections, By Region - 2022 to 2032
Figure 14: Global Market Attractiveness Index, By Region - 2022 to 2032
Figure 15: North America Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032
Figure 16: North America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 17: North America Market Share, By Product Type, 2022 to 2032
Figure 18: North America Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032
Figure 19: North America Market Attractiveness Index, By Product Type - 2022 to 2032
Figure 20: North America Market Share, By End-User, 2022 to 2032
Figure 21: North America Market Y-o-Y Growth Projections, By End-User - 2022 to 2032
Figure 22: North America Market Attractiveness Index, By End-User - 2022 to 2032
Figure 23: North America Market Share, By Application, 2022 to 2032
Figure 24: North America Market Y-o-Y Growth Projections, By Application - 2022 to 2032
Figure 25: North America Market Attractiveness Index, By Application - 2022 to 2032
Figure 26: North America Market Share, By Country, 2022 to 2032
Figure 27: North America Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 28: North America Market Attractiveness Index, By Country - 2022 to 2032
Figure 29: Latin America Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032
Figure 30: Latin America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 31: Latin America Market Share, By Product Type, 2022 to 2032
Figure 32: Latin America Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032
Figure 33: Latin America Market Attractiveness Index, By Product Type - 2022 to 2032
Figure 34: Latin America Market Share, By End-User, 2022 to 2032
Figure 35: Latin America Market Y-o-Y Growth Projections, By End-User - 2022 to 2032
Figure 36: Latin America Market Attractiveness Index, By End-User - 2022 to 2032
Figure 37: Latin America Market Share, By Application, 2022 to 2032
Figure 38: Latin America Market Y-o-Y Growth Projections, By Application - 2022 to 2032
Figure 39: Latin America Market Attractiveness Index, By Application - 2022 to 2032
Figure 40: Latin America Market Share, By Country, 2022 to 2032
Figure 41: Latin America Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 42: Latin America Market Attractiveness Index, By Country - 2022 to 2032
Figure 43: Europe Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032
Figure 44: Europe Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 45: Europe Market Share, By Product Type, 2022 to 2032
Figure 46: Europe Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032
Figure 47: Europe Market Attractiveness Index, By Product Type - 2022 to 2032
Figure 48: Europe Market Share, By End-User, 2022 to 2032
Figure 49: Europe Market Y-o-Y Growth Projections, By End-User - 2022 to 2032
Figure 50: Europe Market Attractiveness Index, By End-User - 2022 to 2032
Figure 51: Europe Market Share, By Application, 2022 to 2032
Figure 52: Europe Market Y-o-Y Growth Projections, By Application - 2022 to 2032
Figure 53: Europe Market Attractiveness Index, By Application - 2022 to 2032
Figure 54: Europe Market Share, By Country, 2022 to 2032
Figure 55: Europe Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 56: Europe Market Attractiveness Index, By Country - 2022 to 2032
Figure 57: MEA Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032
Figure 58: MEA Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 59: MEA Market Share, By Product Type, 2022 to 2032
Figure 60: MEA Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032
Figure 61: MEA Market Attractiveness Index, By Product Type - 2022 to 2032
Figure 62: MEA Market Share, By End-User, 2022 to 2032
Figure 63: MEA Market Y-o-Y Growth Projections, By End-User - 2022 to 2032
Figure 64: MEA Market Attractiveness Index, By End-User - 2022 to 2032
Figure 65: MEA Market Share, By Application, 2022 to 2032
Figure 66: MEA Market Y-o-Y Growth Projections, By Application - 2022 to 2032
Figure 67: MEA Market Attractiveness Index, By Application - 2022 to 2032
Figure 68: MEA Market Share, By Country, 2022 to 2032
Figure 69: MEA Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 70: MEA Market Attractiveness Index, By Country - 2022 to 2032
Figure 71: Asia Pacific Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032
Figure 72: Asia Pacific Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 73: Asia Pacific Market Share, By Product Type, 2022 to 2032
Figure 74: Asia Pacific Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032
Figure 75: Asia Pacific Market Attractiveness Index, By Product Type - 2022 to 2032
Figure 76: Asia Pacific Market Share, By End-User, 2022 to 2032
Figure 77: Asia Pacific Market Y-o-Y Growth Projections, By End-User - 2022 to 2032
Figure 78: Asia Pacific Market Attractiveness Index, By End-User - 2022 to 2032
Figure 79: Asia Pacific Market Share, By Application, 2022 to 2032
Figure 80: Asia Pacific Market Y-o-Y Growth Projections, By Application - 2022 to 2032
Figure 81: Asia Pacific Market Attractiveness Index, By Application - 2022 to 2032
Figure 82: Asia Pacific Market Share, By Country, 2022 to 2032
Figure 83: Asia Pacific Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 84: Asia Pacific Market Attractiveness Index, By Country - 2022 to 2032
Figure 85: US Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 86: US Market Share, By Product Type, 2021
Figure 87: US Market Share, By End-User, 2021
Figure 88: US Market Share, By Application, 2021
Figure 89: Canada Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 90: Canada Market Share, By Product Type, 2021
Figure 91: Canada Market Share, By End-User, 2021
Figure 92: Canada Market Share, By Application, 2021
Figure 93: Brazil Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 94: Brazil Market Share, By Product Type, 2021
Figure 95: Brazil Market Share, By End-User, 2021
Figure 96: Brazil Market Share, By Application, 2021
Figure 97: Mexico Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 98: Mexico Market Share, By Product Type, 2021
Figure 99: Mexico Market Share, By End-User, 2021
Figure 100: Mexico Market Share, By Application, 2021
Figure 101: Germany Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 102: Germany Market Share, By Product Type, 2021
Figure 103: Germany Market Share, By End-User, 2021
Figure 104: Germany Market Share, By Application, 2021
Figure 105: UK Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 106: UK Market Share, By Product Type, 2021
Figure 107: UK Market Share, By End-User, 2021
Figure 108: UK Market Share, By Application, 2021
Figure 109: France Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 110: France Market Share, By Product Type, 2021
Figure 111: France Market Share, By End-User, 2021
Figure 112: France Market Share, By Application, 2021
Figure 113: Italy Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 114: Italy Market Share, By Product Type, 2021
Figure 115: Italy Market Share, By End-User, 2021
Figure 116: Italy Market Share, By Application, 2021
Figure 117: Spain Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 118: Spain Market Share, By Product Type, 2021
Figure 119: Spain Market Share, By End-User, 2021
Figure 120: Spain Market Share, By Application, 2021
Figure 121: Nordic Countries Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 122: Nordic Countries Market Share, By Product Type, 2021
Figure 123: Nordic Countries Market Share, By End-User, 2021
Figure 124: Nordic Countries Market Share, By Application, 2021
Figure 125: China Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 126: China Market Share, By Product Type, 2021
Figure 127: China Market Share, By End-User, 2021
Figure 128: China Market Share, By Application, 2021
Figure 129: Japan Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 130: Japan Market Share, By Product Type, 2021
Figure 131: Japan Market Share, By End-User, 2021
Figure 132: Japan Market Share, By Application, 2021
Figure 133: South Korea Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 134: South Korea Market Share, By Product Type, 2021
Figure 135: South Korea Market Share, By End-User, 2021
Figure 136: South Korea Market Share, By Application, 2021
Figure 137: GCC Countries Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 138: GCC Countries Market Share, By Product Type, 2021
Figure 139: GCC Countries Market Share, By End-User, 2021
Figure 140: GCC Countries Market Share, By Application, 2021
Figure 141: South Africa Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 142: South Africa Market Share, By Product Type, 2021
Figure 143: South Africa Market Share, By End-User, 2021
Figure 144: South Africa Market Share, By Application, 2021
Figure 145: Turkey Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 146: Turkey Market Share, By Product Type, 2021
Figure 147: Turkey Market Share, By End-User, 2021
Figure 148: Turkey Market Share, By Application, 2021
The global Biopsy Guidance System Market is worth more than USD 1.1 Billion at present.
The value of the Biopsy Guidance System Market is projected to increase at a CAGR of around 5.8% from 2022 to 2032.
The value of Biopsy Guidance System Market increased at a CAGR of around 5.1% from 2017 to 2021.
The rising prevalence of cancer, the rise in the geriatric population, the growing demand for non-invasive procedures, and technological innovations are all driving the growth of the biopsy guidance system market.
The market for Biopsy Guidance System Market in China is projected to expand at a CAGR of around 7.1% from 2022 to 2032.
While the market in South Korea is expected to grow at nearly 6.7%, the market in Japan is projected to register a CAGR of nearly 7.1% from 2022 to 2032.
Explore Similar Insights
Biopsy Guidance System Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
